Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- ChecktodayChange DetectedThe study record page now displays a 403 Forbidden message, replacing the detailed study information, eligibility criteria, locations, and outcomes sections with a standard access-denied layout.SummaryDifference19%

- Check7 days agoChange DetectedA new page revision label appears, showing Revision: v3.7.0 in place of Revision: v3.6.6, indicating a minor update to the page template or metadata.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new page revision tag 'Revision: v3.6.6' was added. The previous revision tag 'Revision: v3.6.5' was removed.SummaryDifference0.0%

- Check28 days agoChange DetectedA line noting '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding for MOR106-CL-201. This change represents funding metadata and does not affect the study's design or eligibility criteria.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing the previous version and indicating a new deployment of the site.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3, indicating a minor version update; this does not modify the displayed trial information.SummaryDifference0.0%

Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.